Abstract:Background The use of Mohs micrographic surgery (MMS) in melanoma treatment has divided opinion and evidence‐based guidelines are lacking. Objectives This systematic review aimed to analyse clinical outcomes for patients with invasive melanomas treated with Mohs rather than wide local excision (WLE). Methods Embase, MEDLINE and Cochrane databases (to 30 August 2023) were searched for studies using Mohs to treat invasive melanoma. Outcomes of interest were local recurrence and death from melanoma. Results Thirty‐five articles involving 41,499 patients with invasive melanoma treated with Mohs were identified. Sixteen studies compared Mohs with WLE and 19 were Mohs‐only, non‐comparative studies. Patients treated with Mohs differed significantly from those undergoing WLE, in particular Mohs patients were older and had thinner melanomas. Two comparative studies using the same data source reported adjusted hazard ratios for melanoma‐specific death and both showed no significant difference between Mohs and WLE‐treated patients; 0.87 (95% CI 0.55–1.35) and 1.20 (95% CI 0.71–20.36). There was also no statistically significant difference in local recurrence risk; the unadjusted risk ratio for patients treated with Mohs was 0.46 (95% CI 0.14–1.51 p = 0.20) with moderate heterogeneity (I2 = 62%). No studies reported multivariable analyses for risk of local recurrence. Many studies generated from relatively few and often overlapping data sets have reported the use of Mohs to treat patients with invasive melanoma. Fewer studies were comparative between Mohs and WLE and these reported substantially different baseline risks of recurrence and death from melanoma between the groups. Mohs has generally been used for thinner melanomas in older patients; therefore, comparisons based on univariable analyses are likely to have been misleading. Conclusions On the basis of currently available data, it is not possible to reliably assess whether outcomes differ if invasive melanomas with comparable features are treated with Mohs or WLE, and randomized trial evidence will be required for reliable conclusions to be reached.

Clinical Versus Histologic Margins for Cutaneous Squamous Cell Carcinoma: Comparing Outcomes for High-Risk Tumors Treated With Mohs Micrographic Surgery

Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas

Factors Influencing Margin Clearance and the Number of Stages of Mohs Micrographic Surgery in Basal Cell Carcinoma: A Retrospective Chart Review

Mohs Micrographic Surgery for Invasive Melanoma Allows for Tissue Preservation Compared With Wide Local Excision: A Retrospective Cohort Study

Surgical Margins of Nonmelanoma Skin Cancers in Mohs Surgery: Dermoscopy Versus Naked Eye

Mohs micrographic technique in high-risk basal cell carcinoma: a 3D prediction of safety margins

Excision Margins for Melanoma in Situ on the Head and Neck – A Single-Center 10-year Retrospective Review of Treatment with Mohs Micrographic Surgery

Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.

Mohs Micrographic Surgery in the Surgical Treatment Paradigm of Melanoma In Situ and Invasive Melanoma: A Clinical Review of Treatment Efficacy and Ongoing Controversies

Using optical coherence tomography to optimize Mohs micrographic surgery

Mohs Micrographic Surgery: A Brief Overview

Mohs micrographic surgery for the treatment of invasive melanoma: A systematic review with meta‐analyses

Intraoperative Immunohistochemistry During Mohs Micrographic Surgery and Staged Excision Decreases Local Recurrence Rates for Invasive Cutaneous Melanoma: A Systematic Review and Meta-Analysis

Enhanced Disease-Specific Survival Among Individuals With Malignant Adnexal Tumors of the Skin Treated With Mohs Surgery: A National Database Study

Treatment of sebaceous carcinoma with Mohs micrographic surgery versus wide local excision: a systematic review

micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities

Primary site surgical resection in cM1 oral cavity squamous cell carcinoma

[Modified Mohs Micrographic Surgery in the Treatment of Cutaneous Melanoma].

Predictors of psychosocial outcomes of Mohs micrographic surgery: a review

A review of Mohs micrographic surgery for skin cancer. Part 1: Melanoma and rare skin cancers

Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma